The cost of feedback microwave thermotherapy compared with transurethral resection of the prostate for treating benign prostatic hyperplasia

BJU International

Volumn 93, Issue 4, 2004, Pages 543-548

  Kobelt, G ^a,b   Spangberg A ^c   Mattiasson, A ^d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b European Health Economics ^*  (France)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cost; Microwave therapy; PLFT; TURP

Indexed keywords

AGED; ARTICLE; BLADDER NECK INCISION; BLEEDING; BURNING SENSATION; CLINICAL PRACTICE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEEDBACK SYSTEM; HEALTH CARE COST; HOSPITALIZATION; HUMAN; INCISION; INFECTION; MAJOR CLINICAL STUDY; MALE; MICROWAVE THERAPY; MICTURITION; MULTICENTER STUDY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RANDOMIZED CONTROLLED TRIAL; REGISTER; SYMPTOMATOLOGY; TECHNIQUE; TRANSURETHRAL RESECTION; URGE INCONTINENCE; URINE RETENTION; INTERMETHOD COMPARISON; QUESTIONNAIRE; RETROSPECTIVE STUDY; SCORING SYSTEM; TREATMENT OUTCOME; URINE FLOW RATE;

AGED; COSTS AND COST ANALYSIS; FEEDBACK; FOLLOW-UP STUDIES; HUMANS; HYPERTHERMIA, INDUCED; MALE; PROSTATIC HYPERPLASIA; RETROSPECTIVE STUDIES; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 1642414925     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2003.04689.x     Document Type: Article

References (33)

1. Hald T, Nordling J. Nonsurgical, nonpharmacologic treatment of benign prostatic hyperplasia. Cancer 1992; 70: 346-50
2. de la Rosette JJ, d'Ancona F, Debruyne F. Current status of thermotherapy of the prostate. J Urol 1997; 157: 430-8
3. Anson K, Watson G. The current status of the use of lasers in the treatment of benign prostatic hyperplasia. Br J Urol 1995; 75: 34-41
4. Madersbacher S, Marberger M. Is transurethral resection of the prostate still justified? Br J Urol 1999; 83: 227-37
5. Kortt M, Bootman J. The economics of benign prostatic hyperplasia treatment: a literature review. Clin Therapeutics 1996; 18: 1227-41
6. Anonymous. Benign prostatic hypertrophy: 'cost-benefit' of surgery greater than that of drug therapy. Drugs Ther Perspectives 1997; 10:
7. Stoevelaar H, McDonnell J. Changing therapeutic regimens in benign prostatic hyperplasia. Pharmacoeconomics 2001; 19: 131-53
8. Denis L, Griffith K, Khoury S et al. The economics of the management of lower urinary tract symptoms and benign prostatic hyperplasia. In 4th International Consultation on Benign Prostatic Hyperplasia (BPH), Paris. Plymouth: Health Publications Ltd, 1997
9. Schulman C. The economics of treatment of benign prostatic hyperplasia. Eur Urol 1996; 29: 399
10. Chirikos T, Sanford E. Cost consequences of surveillance, medical management or surgery for benign prostatic hyperplasia. J Urol 1996; 155: 1311-6
11. Holtgreve H. The medical management of lower urinary tract symptoms and benign prostatic hyperplasia. Urol Clin North Am 1998; 25: 555-69
12. Eri L, Tveter K. Treatment of benign prostatic hyperplasia: a pharmacoeconomic perspective. Drugs Ageing 1997; 10: 107-18
13. Baladi J, Menon D, Otten N. An economic evaluation of finasteride for the treatment of benign prostatic hyperplasia. Pharmacoeconomics 1996; 9: 443-54
14. Baladi J-P. Cost-effectiveness and cost-utility analyses of finasteride therapy for the treatment of benign prostatic hyperplasia. Ontario: Canadian Coordinating Office for Health Technology Assessment, 1995
15. Cockrum P, Finder S, Ries A, Potyk R. A pharmacoeconomic analysis of patients with symptoms of benign prostatic hyperplasia. Pharmacoeconomics 1997; 11: 550-65
16. Walden M, Acosta S, Carlsson P, Petterson S, Dahlstrand C. A cost-effectiveness analysis of transurethral resection of the prostate and transurethral microwave thermotherapy for the treatment of benign prostatic hyperplasia: a two year follow-up. Scand J Urol Nephrol 1998; 32: 204-10
17. Norby B, Nielsen H, Frimodt-Moller P. Cost-effectiveness of new treatments for benign prostatic hyperplasia. Scand J Urol Nephrol 2002; 36: 286-95
18. Wagrell L, Schelin S, Nordlin J et al. Feedback microwave thermotherapy versus TURP for clinical BPH - A randomized controlled multicenter study. Urology 2002; 60: 292-9
19. Chatelain C, Denis L, Foo K, Khoury S, McConnell J. Benign Prostatic Hyperplasia, 5th consultation on benign prostatic hyperplasia (BPH). Paris. Plymouth: Health Publications Ltd, 2000
20. The EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990: 199-208
21. Dolan P, Gudex C, Kind P, Williams A. A social tariff for EuroQol: Results from a UK general population survey. York: Centre for Health Economics. University of York, 1995
22. National Board of Health and Welfare. Swedish Inpatient Registry. Stockholm: Epidemiological Centrum, 2002
23. Denis L, Griffith K, Khoury S et al. 4th International Consultation on Benign Prostatic Hyperplasia (BPH), Paris. Plymouth: Health Publications Ltd, 1997
24. DeWildt M, d'Ancona F, Hubregtse M et al. Three-year follow-up of patients treated with lower energy microwave thermotherapy. J Urol 1996; 156: 1959-63
25. Hallin A, Berlin T. Transurethral microwave thermotherapy for benign prostatic hyperplasia: clinical outcome after 4 years. J Urol 1998; 159: 459-64
26. Glass J, Bdesha A, Witherow R. Microwave thermotherapy, a long-term follow-up of 67 patients from a single centre. Br J Urol 1998; 81: 377-82
27. Lau K, Li M, Foo K. Long-term follow-up of transurethral microwave thermotherapy. Urology 1998; 52: 829-33
28. Daehlin L, Frugard J. Three-year follow-up after transurethral microwave thermotherapy for benign postatic hyperplasia using the PRIMUS U+R device. Scand J Urol Nephrol 1999; 33: 217-21
29. d'Ancona F, Francisca E, Debruyne F, de la Rosette JJ. High-energy transurethral microwave thermotherapy in men with lower urinary tract symptoms. J Endourol 1997; 11: 285-9
30. Ramsey E, Miller P, Parsons K. Transurethral microwave thermotherapy in the treatment of benign prostatic hyperplasia: results obtained with the Urologix T3 device. World J Urol 1998; 16: 96-101
31. Thalmann G, Mattei A, Threuthardt C, Burkhard F, Studer U. Transurethral microwave therapy in 200 patients with a minimum follow-up of 2 years: urodynamic and clinical results. J Urol 2002; 167: 2496-501
32. Djavan B, de la Rosette JJ, Desgrandchamps F et al. Interventional therapy of benign prostatic hyperplasia. In Chatellain C, Denis L, Foo K, Khoury S, Connell J eds 5th International Consultation on Benign Prostatic Hyperplasia. Plymouth: Plymbridge Distributers Ltd, 2001: 399-421
33. Mattiasson A, Schelin S, Magnusson B et al. ProstaLund microwave feedback treatment compared with TURP for treatment of bph. a prospective randomized multicenter study with 36 months follow up. EAU Madrid 2003: Poster 412